skip to main content
Idioma:
Primo Search
Clear Search Box
Search in: Busca Geral
Busca Avançada
Busca por Índices

Depression‐resistant endophenotype in mice overexpressing cannabinoid CB2 receptors

García‐Gutiérrez, MS ; Pérez‐Ortiz, JM ; Gutiérrez‐Adán, A ; Manzanares, J

British journal of pharmacology, 2010-08, Vol.160 (7), p.1773-1784 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
  • Título:
    Depression‐resistant endophenotype in mice overexpressing cannabinoid CB2 receptors
  • Autor: García‐Gutiérrez, MS ; Pérez‐Ortiz, JM ; Gutiérrez‐Adán, A ; Manzanares, J
  • Assuntos: Adult and adolescent clinical studies ; antidepressant ; behaviour ; Biological and medical sciences ; brain‐derived neurotrophic factor ; CB2 receptor ; Depression ; Medical sciences ; Mood disorders ; Pharmacology. Drug treatments ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Research Papers ; transgenic mice ; unpredictable chronic mild stress
  • É parte de: British journal of pharmacology, 2010-08, Vol.160 (7), p.1773-1784
  • Descrição: Background and purpose:  The present study evaluated the role of CB2 receptors in the regulation of depressive‐like behaviours. Transgenic mice overexpressing the CB2 receptor (CB2xP) were challenged with different types of acute and chronic experimental paradigms to evaluate their response in terms of depressive‐like behaviours. Experimental approach:  Tail suspension test (TST), novelty‐suppressed feeding test (NSFT) and unpredictable chronic mild stress tests (CMS) were carried out in CB2xP mice. Furthermore, acute and chronic antidepressant‐like effects of the CB2 receptor‐antagonist AM630 were evaluated by means of the forced swimming test (FST) and CMS, respectively, in wild‐type (WT) and CB2xP mice. CB2 gene expression, brain‐derived neurotrophic factor (BDNF) gene and protein expressions were studied in mice exposed to CMS by real‐time PCR and immunohistochemistry, respectively. Key results:  Overexpression of CB2 receptors resulted in decreased depressive‐like behaviours in the TST and NSFT. CMS failed to alter the TST and sucrose consumption in CB2xP mice. In addition, no changes in BDNF gene and protein expression were observed in stressed CB2xP mice. Interestingly, acute administration of AM630 (1 and 3 mg·kg−1, i.p.) exerted antidepressant‐like effects on the FST in WT, but not in CB2xP mice. Chronic administration of AM630 for 4 weeks (1 mg·kg−1; twice daily, i.p.) blocked the effects of CMS on TST, sucrose intake, CB2 receptor gene, BDNF gene and protein expression in WT mice. Conclusion and implications:  Taken together, these results suggest that increased CB2 receptor expression significantly reduced depressive‐related behaviours and that the CB2 receptor could be a new potential therapeutic target for depressive‐related disorders.
  • Editor: Oxford, UK: Blackwell Publishing Ltd
  • Idioma: Inglês
Links
Voltar para lista de resultados

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.